{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:07:49Z","timestamp":1791173269114,"version":"4.1.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,8]],"date-time":"2014-04-08T00:00:00Z","timestamp":1396915200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0094302","type":"journal-article","created":{"date-parts":[[2014,4,8]],"date-time":"2014-04-08T21:49:46Z","timestamp":1396993786000},"page":"e94302","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Identification of Resveratrol Oligomers as Inhibitors of Cystic Fibrosis Transmembrane Conductance Regulator by High-Throughput Screening of Natural Products from Chinese Medicinal Plants"],"prefix":"10.1371","volume":"9","author":[{"given":"Yaofang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonghui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,4,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"a009563","DOI":"10.1101\/cshperspect.a009563","article-title":"Physiology of epithelial chloride and fluid secretion","volume":"2","author":"RA Frizzell","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.physiol.62.1.535","article-title":"Chloride secretion by the intestinal epithelium: Molecular basis and regulatory aspects","volume":"62","author":"KE Barrett","year":"2000","journal-title":"Annu Rev Physiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"G82","DOI":"10.1152\/ajpgi.00245.2010","article-title":"Physiological relevance of cell-specific distribution patterns of CFTR, NKCC1, NBCe1, and NHE3 along the crypt-villus axis in the intestine","volume":"300","author":"RL Jakab","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MOG.0b013e3283358a45","article-title":"Ion transport in the small intestine","volume":"26","author":"J Venkatasubramanian","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev.physiol.62.1.467","article-title":"Role of CFTR in the colon","volume":"62","author":"R Greger","year":"2000","journal-title":"Annu Rev Physiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"JR Riordan","year":"1989","journal-title":"Science"},{"key":"ref7","first-page":"1","article-title":"The cystic fibrosis transmembrane conductance regulator and its function in epithelial transport","volume":"137","author":"K Kunzelmann","year":"1999","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/j.1460-2075.1994.tb06355.x","article-title":"Activation of intestinal CFTR Cl<sup>\u2212<\/sup> channel by heat-stable enterotoxin and guanylin via cAMP-dependent protein kinase","volume":"13","author":"AC Chao","year":"1994","journal-title":"EMBO J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.7524148","article-title":"Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model","volume":"266","author":"SE Gabriel","year":"1994","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI0216112","article-title":"Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion","volume":"110","author":"T Ma","year":"2002","journal-title":"J Clin Invest"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/11313570-000000000-00000","article-title":"Therapeutic potential of cystic fibrosis transmembrane conductance regulator (CFTR) inhibitors in polycystic kidney disease","volume":"23","author":"H Li","year":"2009","journal-title":"BioDrugs"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1146\/annurev.biochem.75.103004.142532","article-title":"CFTR function and prospects for therapy","volume":"77","author":"JR Riordan","year":"2008","journal-title":"Annu Rev Biochem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1085\/jgp.200409059","article-title":"Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy","volume":"124","author":"C Muanprasat","year":"2004","journal-title":"J Gen Physiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.2174\/13816128113199990321","article-title":"CFTR inhibitors","volume":"19","author":"AS Verkman","year":"2013","journal-title":"Curr Pharm Des"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"C1734","DOI":"10.1152\/ajpcell.2001.281.5.C1734","article-title":"Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists","volume":"281","author":"LV Galietta","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.bjp.0704882","article-title":"Correction of G551D-CFTR transport defect in epithelial monolayers by genistein but not by CPX or MPB-07","volume":"137","author":"O Zegarra-Moran","year":"2002","journal-title":"Br J Pharmacol"},{"key":"ref17","first-page":"334","article-title":"Synthesis and characterization of a small molecule thiazolidinone CFTR chloride channel inhibitor","volume":"20","author":"C He","year":"2004","journal-title":"Chem Res Chinese U"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"35079","DOI":"10.1074\/jbc.M303098200","article-title":"Nanomolar Affinity Small Molecule Correctors of Defective {Delta}F508-CFTR Chloride Channel Gating","volume":"278","author":"H Yang","year":"2003","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"37235","DOI":"10.1074\/jbc.M205932200","article-title":"High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening","volume":"277","author":"T Ma","year":"2002","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1085\/jgp.201010518","article-title":"On the mechanism of CFTR inhibition by a thiazolidinone derivative","volume":"136","author":"Z Kopeikin","year":"2010","journal-title":"J Gen Physiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0165-6147(99)01386-3","article-title":"Molecular pharmacology of the CFTR Cl<sup>\u2212<\/sup> channel","volume":"20","author":"TC Hwang","year":"1999","journal-title":"Trends Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1152\/physrev.1999.79.1.S23","article-title":"Structure and function of the CFTR chloride channel","volume":"79","author":"DN Sheppard","year":"1999","journal-title":"Physiol Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","article-title":"Natural products: a continuing source of novel drug leads","volume":"1830","author":"GM Cragg","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"ref24","first-page":"608","article-title":"The future of natural products as a source of new antibiotics","volume":"8","author":"A Luzhetskyy","year":"2007","journal-title":"Curr Opin Investig Drugs"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1168243","article-title":"Drug discovery and natural products: end of an era or an endless frontier","volume":"325","author":"JW Li","year":"2009","journal-title":"Science"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1271\/bbb.110022","article-title":"Greater effectiveness of <italic>\u03b5<\/italic>-viniferin in red wine than its monomer resveratrol for inhibiting vascular smooth muscle cell proliferation and migration","volume":"75","author":"N Zghonda","year":"2011","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1021\/jf050122g","article-title":"Determination of stilbenes (<italic>delta<\/italic>-viniferin, <italic>trans<\/italic>-astringin, <italic>trans<\/italic>-piceid, <italic>cis<\/italic>- and <italic>trans<\/italic>-resveratrol, <italic>epsilon<\/italic>-viniferin) in Brazilian wines","volume":"53","author":"X Vitrac","year":"2005","journal-title":"J Agric Food Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/jf010794g","article-title":"Levels of stilbene oligomers and astilbin in French varietal wines and in grapes during noble rot development","volume":"50","author":"N Landrault","year":"2002","journal-title":"J Agric Food Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.biochi.2011.11.001","article-title":"Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and *NO bioavailability: Potential benefits to cardiovascular diseases","volume":"94","author":"M Frombaum","year":"2012","journal-title":"Biochimie"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fphar.2012.00141","article-title":"Resveratrol: <italic>French paradox<\/italic> revisited","volume":"3","author":"B Catalgol","year":"2012","journal-title":"Front Pharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"8632","DOI":"10.1021\/jf201561e","article-title":"Resveratrol oligomers isolated from Carex species inhibit growth of human colon tumorigenic cells mediated by cell cycle arrest","volume":"59","author":"A Gonz\u00e1lez-Sarr\u00edas","year":"2011","journal-title":"J Agric Food Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.phymed.2011.06.015","article-title":"Neuroprotection of the leaf and stem of <italic>Vitis amurensis<\/italic> and their active compounds against ischemic brain damage in rats and excitotoxicity in cultured neurons","volume":"19","author":"JY Kim","year":"2012","journal-title":"Phytomedicine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1113\/expphysiol.2003.027003","article-title":"Effects of a new cystic fibrosis transmembrane conductance regulator inhibitor on Cl<sup>\u2212<\/sup> conductance in human sweat ducts","volume":"89","author":"XF Wang","year":"2004","journal-title":"Exp Physiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1021\/jf010676t","article-title":"Antioxidant properties of trans-epsilon-viniferin as compared to stilbene derivatives in aqueous and nonaqueous media","volume":"50","author":"C Privat","year":"2002","journal-title":"J Agric Food Chem"},{"key":"ref35","first-page":"57","article-title":"Stilbene compounds: from the grapevine to wine","volume":"25","author":"L Bavaresco","year":"1999","journal-title":"Drugs Exp Clin Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00280-010-1525-4","article-title":"Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats","volume":"68","author":"IM Kapetanovic","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1124\/dmd.104.000885","article-title":"High absorption but very low bioavailability of oral resveratrol in humans","volume":"32","author":"T Walle","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"9003","DOI":"10.1158\/0008-5472.CAN-10-2364","article-title":"Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis","volume":"70","author":"VA Brown","year":"2010","journal-title":"Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/11531820-000000000-00000","article-title":"Steady-State pharmacokinetics and tolerability of <italic>trans<\/italic>-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects","volume":"49","author":"C la Porte","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"ref40","first-page":"772","article-title":"CFTR chloride channel is a molecular target of the natural cancer preventive agent resveratrol","volume":"68","author":"S Yang","year":"2013","journal-title":"Pharmazie"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e81589","DOI":"10.1371\/journal.pone.0081589","article-title":"Resveratrol enhances airway surface liquid depth in sinonasal epithelium by increasing cystic fibrosis transmembrane conductance regulator open probability","volume":"8","author":"S Zhang","year":"2013","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0094302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T14:26:34Z","timestamp":1589034394000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0094302"}},"subtitle":[],"editor":[{"given":"Stefan","family":"W\u00f6lfl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,8]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0094302","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,8]]}}}